Morbidity of ventricular cerebrospinal fluid shunt surgery in adults: An 8-year study

Neurosurgery

Volumn 68, Issue 4, 2011, Pages 985-994

  Korinek, Anne Marie ^a,c   Fulla Oller, Laurence ^a   Boch, Anne Laure ^a   Golmard, Jean Louis ^b   Hadiji, Bassem ^a   Puybasset, Louis ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Hop Pitie Salpetriere   (France)

Author keywords

Cerebrospinal fluid shunt; Risk factors for shunt infection; Shunt failure; Shunt infection

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; VANCOMYCIN;

ADULT; ANASTOMOSIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CEREBROSPINAL FLUID SHUNTING; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; SHUNT DYSFUNCTION; SHUNT INFECTION;

ADULT; AGED; CEREBROSPINAL FLUID RHINORRHEA; CEREBROSPINAL FLUID SHUNTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCEPHALUS; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REOPERATION; RETROSPECTIVE STUDIES; TIME FACTORS; VENTRICULOSTOMY;

EID: 79952901170     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318208f360     Document Type: Article

References (36)

1. Patwardhan RV, Nanda A. Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery. 2005;56(1):139-144; discussion 144-145.
2. Tuli S, Drake J, Lawless J, Wigg M, Lamberti-Pasculli M. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg 2000;92(1):31-38.
3. Borgbjerg BM, Gjerris F, Albeck MJ, Hauerberg J, Borgesen SE. Frequency and causes of shunt revisions in different cerebrospinal fluid shunt types. Acta Neurochir (Wien). 1995;136(3-4):189-194.
4. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien). 1995;136(1-2):1-7.
5. Slight PH, Gundling K, Plotkin SA, et al. A trial of vancomycin for prophylaxis of infections after neurosurgical shunts. N Engl J Med. 1985;312(14):921.
6. Bayston R, Bannister C, Boston V, et al. A prospective randomised controlled trial of antimicrobial prophylaxis in hydrocephalus shunt surgery. Z Kinderchir. 1990;45(Suppl 1):5-7.
7. Overturf GD. Defining bacterial meningitis and other infections of the central nervous system. Pediatr Crit Care Med. 2005;6(3 Suppl):S14-S18.
8. Simon TD, Riva-Cambrin J, Srivastava R, et al. Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatr. 2008;1(2):131-137.
9. Puca A, Anile C, Maira G, Rossi G. Cerebrospinal fluid shunting for hydrocephalus in the adult: factors related to shunt revision. Neurosurgery. 1991;29(6):822-826.
10. Lund-Johansen M, Svendsen F, Wester K. Shunt failures and complications in adults as related to shunt type, diagnosis, and the experience of the surgeon. Neurosurgery. 1994;35(5):839-844; discussion 844.
11. Hebb AO, Cusimano MD. Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome. Neurosurgery. 2001;49(5):1166-1184; discussion 1184-1186.
12. McGirt MJ, Woodworth G, Coon AL, et al. Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(4):699-705; discussion 699-705.
13. Choksey MS, Malik IA. Zero tolerance to shunt infections: can it be achieved? J Neurol Neurosurg Psychiatry. 2004;75(1):87-91.
14. Ferguson SD, Michael N, Frim DM. Observations regarding failure of cerebrospinal fluid shunts early after implantation. Neurosurg Focus. 2007; 22(4):E7.
15. Wu Y, Green NL, Wrensch MR, Zhao S, Gupta N. Ventriculoperitoneal shunt complications in California: 1990 to 2000. Neurosurgery. 2007;61(3):557-562; discussion 562-563.
16. Thompson DN, Hartley JC, Hayward RD. Shunt infection: is there a near-miss scenario? J Neurosurg. 2007;106(1 Suppl):15-19.
17. Lazareff JA, Peacock W, Holly L, et al. Multiple shunt failures: an analysis of relevant factors. Childs Nerv Syst 1998;14(6):271-275.
18. Del Bigio MR. Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology. Neurosurgery. 1998;42(2):319-325; discussion 325-326.
19. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001;94(2):195-201.
20. Kestle JR, Garton HJ, Whitehead WE, et al. Management of shunt infections: a multicenter pilot study. J Neurosurg. 2006;105(3 Suppl):177-181.
21. Odio C, McCracken GH Jr, Nelson JD. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child. 1984;138(12):1103-1108.
22. McGirt MJ, Zaas A, Fuchs HE, et al. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis. 2003;36(7):858-862.
23. Tulipan N, Cleves MA. Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection. J Neurosurg. 2006;104 (1 Suppl):5-8.
24. Bayston R, Leung TS, Wilkins BM, Hodges B. Bacteriological examination of removed cerebrospinal fluid shunts. J Clin Pathol. 1983;36(9):987-990.
25. Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM. Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 2001;35(2): 66-71.
26. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF. Factors causing acute shunt infection. Computer analysis of 1174 operations. J Neurosurg. 1984;61(6):1072-1078.
27. Ragel BT, Browd SR, Schmidt RH. Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents. J Neurosurg. 2006;105(2):242-247.
28. Pattavilakom A, Xenos C, Bradfield O, Danks RA. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci. 2007;14(6):526-531.
29. Parker SL, Attenello FJ, Sciubba DM, et al. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst. 2009;25(1):77-83; discussion 85.
30. Sciubba DM, Lin LM, Woodworth GF, et al. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus. 2007;22(4):E9.
31. Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst. 2007;23(7):773-777.
32. Ritz R, Roser F, Morgalla M, et al. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis. 2007;7(5):38.
33. Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg. 1992;77(6):875-880.
34. Pirotte BJ, Lubansu A, Bruneau M, et al. Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures. Childs Nerv Syst 2007;23(11):1251-1261.
35. Stamos JK, Kaufman BA, Yogev R. Ventriculoperitoneal shunt infections with gram-negative bacteria. Neurosurgery. 1993;33(5):858-862.
36. Duhaime AC. Evaluation and management of shunt infections in children with hydrocephalus. Clin Pediatr (Phila). 2006;45(8):705-713.